• Cisplatin (CDDP): Molecular Insights and Advanced Assay Desi

  2026-05-19

  Explore the molecular intricacies of Cisplatin (CDDP) and its transformative impact on apoptosis assays and chemoresistance research. This article delivers a unique bridge between DNA damage mechanisms and RNA m6A regulation, offering actionable guidance for advanced experimental workflows.

• Diclofenac: Non-Selective COX Inhibitor for Organoid Assays

  2026-05-18

  Diclofenac stands out as a non-selective COX inhibitor, enabling precise interrogation of inflammation signaling in advanced human stem cell-derived intestinal organoid models. This article details optimized workflows, troubleshooting, and experimental innovations using high-purity Diclofenac from APExBIO, directly contextualized by the latest organoid pharmacokinetic research.

• 5-Methyl-CTP: Enhancing mRNA Synthesis for Advanced Vaccines

  2026-05-18

  5-Methyl-CTP enables robust, stable, and translationally efficient mRNA production for personalized vaccine and therapeutic workflows. Its integration into in vitro transcription protocols directly addresses the persistent bottlenecks of mRNA instability and limited translation, streamlining experimental design for researchers in cutting-edge gene expression and mRNA drug development.

• Cy3-UTP: Illuminating Endosomal Escape in RNA Delivery Assay

  2026-05-17

  Explore how Cy3-UTP enables high-sensitivity RNA imaging and mechanistic insights into intracellular trafficking and endosomal escape. This in-depth article delivers unique, evidence-backed guidance for advanced RNA-protein interaction studies using Cy3-modified uridine triphosphate.

• Lysoptosis: Evolutionarily Conserved Cell Death via Cathepsi

  2026-05-16

  Luke et al. (2022) define lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death pathway regulated by intracellular serpins and characterized by lysosomal membrane permeabilization and cathepsin release. This mechanistic distinction clarifies the role of cysteine proteases in regulated cell death and informs experimental strategies for dissecting cell demise in diverse model systems.

• FLAG tag Peptide: Precision Epitope Tag for Protein Purifica

  2026-05-15

  The FLAG tag Peptide (DYKDDDDK) stands out for its high solubility, enterokinase-cleavable design, and exceptional specificity in recombinant protein workflows. This article explores experimental protocols, real-world troubleshooting, and practical optimizations that maximize data fidelity in protein purification and detection.

• Disulfiram: Proteasome Inhibition and Cancer Cell Death Evid

  2026-05-15

  Disulfiram is a dopamine β-hydroxylase inhibitor and copper-binding proteasome inhibitor with proven efficacy in inducing apoptotic cancer cell death. Its solubility profile and mechanism make it a robust tool for breast cancer and proteasome research. Data from APExBIO and peer-reviewed studies support its use in translational oncology.

• Pexmetinib (ARRY-614): Optimizing Dual Inhibition in Cytokin

  2026-05-14

  Pexmetinib (ARRY-614) uniquely enables robust, dual inhibition of p38 MAPK and Tie2, offering researchers potent, nanomolar-level control over cytokine synthesis in inflammation and hematologic malignancy models. Discover advanced workflow enhancements, troubleshooting insights, and practical assay design rooted in the latest structural and cellular breakthroughs.

• TPPU: Unlocking Hepatic sEH Inhibition for Bone and Inflamma

  2026-05-14

  Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, reveals new regulatory links between liver-derived lipid signaling and bone homeostasis. This article offers in-depth, protocol-driven insights for researchers targeting inflammation and osteoporosis models.

• Allosteric Degradation of XPO1 by SINEs: Mechanistic Insight

  2026-05-13

  Wing et al. (2025) uncover a new allosteric mechanism by which SINE compounds induce the degradation of exportin 1 (XPO1), a key nuclear export receptor. Their cryo-EM and biochemical studies reveal that SINEs expose a cryptic ASB8 binding site on XPO1, thereby engaging the Cullin–RING E3 ligase pathway for targeted ubiquitination and degradation, extending the conceptual framework of targeted protein degradation.

• FLAG tag Peptide (DYKDDDDK): Precision Tagging in Molecular

  2026-05-13

  Explore how the FLAG tag Peptide (DYKDDDDK) enables high-fidelity recombinant protein detection and mechanistic studies. This article reveals unique insights into its use for dissecting adaptor-motor interactions and optimizing affinity workflows.

• IPA-3: Mechanistic Insights and Strategic Guidance for Trans

  2026-05-12

  This thought-leadership article delivers an advanced exploration of IPA-3, a selective, non-ATP-competitive Pak1 inhibitor from APExBIO, focusing on its mechanistic selectivity, translational relevance, and actionable guidance for researchers. Integrating recent literature and practical protocols, the piece addresses both the promise and limitations of targeting Pak1, particularly in neuroinflammation and cancer biology, and clarifies the compound's role in cross-domain research. Unique in its evidence-based approach, this article surpasses basic product summaries by providing strategic direction grounded in mechanistic insight and real-world validation.

• Actinomycin D (A4448): Mechanisms, Protocols & Research Benc

  2026-05-12

  Actinomycin D is a gold-standard transcriptional inhibitor, valued for its potent apoptosis induction and utility in cancer research. Its DNA intercalation mechanism enables precise control of transcriptional stress and mRNA stability assays. APExBIO’s Actinomycin D (A4448) exemplifies high-purity standards for modern molecular workflows.

• 3X (DYKDDDDK) Peptide: Next-Gen Affinity Tag in Protein Scie

  2026-05-11

  The 3X (DYKDDDDK) Peptide revolutionizes recombinant protein workflows with its triple-epitope design, enabling higher sensitivity in purification and detection. Leveraging recent structural and functional insights, this guide details experimental setup, advanced applications, and troubleshooting to maximize the utility of the 3X FLAG peptide in translational research.

• 3X (DYKDDDDK) Peptide: Advanced Affinity Tagging for Purific

  2026-05-11

  The 3X (DYKDDDDK) Peptide offers superior sensitivity and minimal structural interference in affinity purification and detection workflows. Leverage robust experimental design and troubleshooting insights to maximize reproducibility in challenging protein studies.

704 records 14/47 page Previous Next First page 上5页 1112131415 下5页 Last page